Considerations for Selecting Samsung Mobile Devices for Global Clinical Trials

Samsung chats with mProve’s New Product Development Lead, Mindy Gruba, about considerations for selecting the right mobile device for each clinical trial. Check out the article here.

Outsourcing-Pharma.com covers mProve’s partnership with Greenphire

Adding patient payment information to mPal via the integration with Greenphire’s ClinCard brings us one step closer to offering patients all the services they could need for any trial.

Read more here.

Pharma Roundtable: Breaking Barriers to Using Mobile Technology on Clinical Trials

As a moderator at the Mobile in Clinical Trials event at DPharm in Boston in early September, CEO Jeff Lee had the opportunity to sit down with some of the pharmaceutical industry’s top mobile expert. He got their perspectives on quantifying and deriving value from mobile technologies, as well as how they get buy-in from study teams and executives to scale the use of these tools. Read the article published by Applied Clinical Trials here.

CenterWatch Weekly, September 18, 2017, Covers mProve and Greenphire’s Partnership

Jeff Lee, CEO, mProve Health, and Jim Murphy, CEO, Greenphire, comment on how their companies are joining forces to allow clinical trial patients real-time mobile access to a range of support functions through mProve’s app. Read more here.

September Issue of PharmaVOICE Covers Patient Engagement Featuring Jeff Lee

Today’s clinical trial patients are digital and health savvy consumers. Check out what Jeff Lee, CEO, mProve Health, and top patient engagement experts from PwC, Rx-Edge, Sciformix, and PMRG/Health Literacy Initiative say about engagement strategies that work for patients in clinical trials. Read the full article here.

Page 1 of 3123